Hib/MenC risk groups: patient group direction (PGD) template
PGD template to support the provision of Hib/MenC vaccine to individuals with underlying medical conditions.
Documents
Details
This patient group direction (PGD) template supports the provision of additional Haemophilus influenzae type b and meningococcal C conjugate vaccine doses to individuals with underlying medical conditions from 2 years of age.
It is valid from 1 November 2018 to 31 October 2020.
Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy/procedures to access authorised PGD documents.
This PGD template should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.
Updates to this page
Last updated 11 October 2018 + show all updates
-
Added routine update.
-
First published.